Heterozygous M1V variant of ELA-2 gene mutation associated with G-CSF refractory severe congenital neutropenia

Pediatric Blood and Cancer

Volumn 57, Issue 3, 2011, Pages 514-515

  Setty, Bhuvana A ^a   Yeager, Nicholas D ^b   Bajwa, Rajinder P ^b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow failure; Neutropenia; White blood cell disorders

Indexed keywords

GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BRONCHIOLITIS; BRONCHOSCOPY; CASE REPORT; CELLULITIS; CLOSTRIDIUM DIFFICILE INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG WITHDRAWAL; DYSERYTHROPOIESIS; ELA 2 GENE; GASTROESOPHAGEAL REFLUX; GENE; GENE MUTATION; GENETIC VARIABILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; HYPERBILIRUBINEMIA; HYPOXIA; INFANT; MALE; NEWBORN INTENSIVE CARE; OMPHALITIS; OXYGEN THERAPY; PHOTOTHERAPY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PREGNANCY; PRIORITY JOURNAL; REFRACTORY PERIOD; SEVERE CONGENITAL NEUTROPENIA; SIBLING; STRIDOR; TRACHEOMALACIA; VIRUS REACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DRUG RESISTANCE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROZYGOTE; HUMANS; INFANT; MALE; MUTATION; NEUTROPENIA; SERINE ENDOPEPTIDASES;

EID: 79960158943     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23018     Document Type: Article

References (14)

1. Boxer LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer 2007; 49: 609-614.
2. Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol 2006; 43: 189-195.
3. Bellanne-Chantelot C, Clauin S, Leblanc T, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: A study of 81 patients from the French Neutropenia Register. Blood 2004; 103: 4119-4125.
4. Boztug K, Klein C. Novel genetic etiologies of severe congenital neutropenia. Curr Opin Immunol 2009; 21: 472-480.
5. Berliner N. Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis. Blood 2008; 111: 5427-5432.
6. Carlsson G, Fasth A. Infantile genetic agranulocytosis, morbus Kostmann: Presentation of six cases from the original "Kostmann family" and a review. Acta Paediatr 2001; 90: 757-764.
7. Horwitz MS, Duan Z, Korkmaz B, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 2007; 109: 1817-1824.
8. Kollner I, Sodeik B, Schreek S, et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 2006; 108: 493-500.
9. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007; 39: 86-92.
10. Zeidler C, Germeshausen M, Klein C, et al. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 2009; 144: 459-467.
11. Germeshausen M, Ballmaier M, Welte K. Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias. Ann NY Acad Sci 2001; 938: 305-320, discussion 320-301.
12. Zeidler C, Boxer L, Dale DC, et al. Management of Kostmann syndrome in the G-CSF era. Br J Haematol 2000; 109: 490-495.
13. Elhasid R, Rowe JM. Hematopoetic stem cell transplantation in neutrophil disorders: Severe congenital neutropenia, leukocyte adhesion deficiency and chronic granulomatous disease. Clin Rev Allergy Immunol 2010; 38: 61-67.
14. Rosenberg PS, Alter BP, Link DC, et al. Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol 2008; 140: 210-213.